Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC(50)10 Randomized Clinical Trial

IMPORTANCE: The prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) remains poor after surgery. Neoadjuvant chemoradiotherapy (NCRT) has been shown to potentially improve survival. OBJECTIVE: To compare the treatment efficacy of NCRT plus surgery with surgery alone...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hong, Liu, Hui, Chen, Yuping, Zhu, Chengchu, Fang, Wentao, Yu, Zhentao, Mao, Weimin, Xiang, Jiaqing, Han, Yongtao, Chen, Zhijian, Yang, Haihua, Wang, Jiaming, Pang, Qingsong, Zheng, Xiao, Yang, Huanjun, Li, Tao, Zhang, Xu, Li, Qun, Wang, Geng, Chen, Baofu, Mao, Teng, Kong, Min, Guo, Xufeng, Lin, Ting, Liu, Mengzhong, Fu, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223138/
https://www.ncbi.nlm.nih.gov/pubmed/34160577
http://dx.doi.org/10.1001/jamasurg.2021.2373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223138/
https://www.ncbi.nlm.nih.gov/pubmed/34160577
http://dx.doi.org/10.1001/jamasurg.2021.2373

Ejemplares similares